Skip to main content

Table 5 Relationship between baseline characteristics and VA at the 12-month follow-up

From: Therapeutic effects of ranibizumab in patients with polypoidal choroidal vasculopathy

Baseline Characteristic P value of the univariate analysis of baseline characteristics and VA at the 12-month follow-up P value of the multivariate analysis of baseline characteristics and VA at the 12-month follow-up
Age 0.24  
Gender 0.16  
Baseline VA < 0.01 < 0.01
Baseline CRT < 0.01  
PED 0.05  
Retinal/subretinal hemorrhage < 0.01  
Subretinal fluids < 0.01 < 0.01
CNV 0.91  
Lesion location 0.90  
Greatest lesion diameter 0.01 < 0.01
  1. VA visual acuity, CRT central retinal thickness, PED pigment epithelial detachment, CNV choroidal neovascularization